Immuron Limited (IMRN): Price and Financial Metrics


Immuron Limited (IMRN)

Today's Latest Price: $3.40 USD

0.11 (-3.24%)

Updated Nov 18 6:55pm

Add IMRN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

IMRN Stock Summary

  • IMRN has a market capitalization of $13,669,315 -- more than approximately just 6.03% of US stocks.
  • The ratio of debt to operating expenses for Immuron Ltd is higher than it is for about only 0.39% of US stocks.
  • With a year-over-year growth in debt of -100%, Immuron Ltd's debt growth rate surpasses just 0% of about US stocks.
  • Stocks that are quantitatively similar to IMRN, based on their financial statements, market capitalization, and price volatility, are STIM, UG, CPST, DBD, and CPIX.
  • IMRN's SEC filings can be seen here. And to visit Immuron Ltd's official web site, go to www.immuron.com.
IMRN Daily Price Range
IMRN 52-Week Price Range

IMRN Stock Price Chart More Charts


IMRN Price/Volume Stats

Current price $3.40
Prev. close $3.51
Day low $3.34
Day high $3.42
50-day MA $3.14
200-day MA $4.38
52-week high $8.79
52-week low $2.23
Volume 5,100
Avg. volume 102,205
Dividend yield N/A
Market Cap 12.17M

Immuron Limited (IMRN) Company Bio


Immuron Limited focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. The company was founded in 1994 and is based in Australia.





IMRN Latest News Stream


Event/Time News Detail
Loading, please wait...

IMRN Latest Social Stream


Loading social stream, please wait...

View Full IMRN Social Stream

IMRN Price Returns

1-mo 2.41%
3-mo 32.81%
6-mo -32.41%
1-year -57.12%
3-year N/A
5-year N/A
YTD N/A
2018 0.00%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.442 seconds.